{"transactions":[{"id":753190,"issuer":{"id":8193,"kind":"organization","name":"Enveric Biosciences, Inc."},"owners":[{"id":42011,"kind":"person","name":"Schabacker Marcus","position":1,"cik":"0001645282","reported_name":"Schabacker Marcus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-03T20:27:08.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":18518,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock granted to the reporting person pursuant to the Enveric Biosciences, Inc. 2020 Long-Term Incentive Plan, as amended (the \"Plan\"). Such\nshares shall vest in accordance with the terms and conditions of the Plan and the reporting person's restricted stock award agreement."}],"balance_after":26418,"source":{"system":"sec-edgar","filing":"0001645282-26-000002","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/890821/000164528226000002/ownership.xml","form_type":"4"}},{"id":957623,"issuer":{"id":8193,"kind":"organization","name":"Enveric Biosciences, Inc."},"owners":[{"id":42011,"kind":"person","name":"Schabacker Marcus","position":1,"cik":"0001645282","reported_name":"Schabacker Marcus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-30T21:39:53.000Z","date":"2025-12-23","kind":"grant","planned":false,"acquired":true,"shares":7633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock granted to the reporting person pursuant to the Enveric Biosciences, Inc. 2020 Long-Term Incentive Plan, as amended (the \"Plan\"). Such\nshares shall vest in accordance with the terms and conditions of the Plan and the reporting person's restricted stock award agreement."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On January 29, 2025, the common stock of the Issuer began trading on a split-adjusted basis, pursuant to which every 15 shares of issued and outstanding common stock\nwere reclassified as one share of common stock (the \"January Reverse Stock Split\"). On October 28, 2025, the common stock of the Issuer began trading on a split-adjusted\nbasis, pursuant to which every 12 shares of issued and outstanding common stock were reclassifed as one share of common stock (the\"October Reverse Stock Split\"\ntogether with the January Reverse Stock Split, the \"Reverse Stock Splits\"). The number of securities reported in this Form 4 has been adjusted to reflect the Reverse Stock\nSplits."}],"balance_after":7900,"source":{"system":"sec-edgar","filing":"0001193125-25-337178","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/890821/000119312525337178/ownership.xml","form_type":"4"}},{"id":1387827,"issuer":{"id":8193,"kind":"organization","name":"Enveric Biosciences, Inc."},"owners":[{"id":42011,"kind":"person","name":"Schabacker Marcus","position":1,"cik":"0001645282","reported_name":"Schabacker Marcus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-11T23:18:57.000Z","date":"2024-10-09","kind":"grant","planned":false,"acquired":true,"shares":47733,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock granted to the reporting person pursuant to the Enveric Biosciences, Inc. 2020 Long-Term Incentive Plan, as amended (the \"Plan\"). Such shares shall vest in full on December 31, 2024, subject to the terms and conditions of the Plan and the reporting person's restricted stock award agreement."}],"balance_after":48053,"source":{"system":"sec-edgar","filing":"0001415889-24-025059","document":"form4-10112024_111054.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/890821/000141588924025059/form4-10112024_111054.xml","form_type":"4"}},{"id":2856183,"issuer":{"id":8193,"kind":"organization","name":"Enveric Biosciences, Inc."},"owners":[{"id":42011,"kind":"person","name":"Schabacker Marcus","position":1,"cik":"0001645282","reported_name":"Schabacker Marcus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-18T00:32:13.000Z","date":"2021-02-15","kind":"grant","acquired":true,"shares":15957,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock granted to the reporting person pursuant to the Enveric Biosciences, Inc. 2020 Long-Term Incentive Plan (the \"Plan\"). Such shares shall vest in full on December 30, 2021, or the one-year anniversary of the date on which the reporting person commenced providing services to the issuer as a member of its board of directors, subject to the terms and conditions of the Plan and the reporting person's restricted stock award agreement."}],"balance_after":15957,"source":{"system":"sec-edgar","filing":"0001493152-21-004176","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/890821/000149315221004176/ownership.xml","form_type":"4"}},{"id":4396447,"issuer":{"id":1707,"kind":"organization","name":"BAXTER INTERNATIONAL INC","symbol":"BAX"},"owners":[{"id":42011,"kind":"person","name":"Schabacker Marcus","position":1,"cik":"0001645282","reported_name":"Schabacker Marcus","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP, Chief Scientific Officer"}}],"security":"Common Stock, $1 par value","published_at":"2017-03-08T21:14:58.000Z","date":"2017-03-06","kind":"tax_withholding","acquired":false,"shares":286,"price":50.68,"value":14494.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares forfeited by the reporting person to cover the payment of taxes incurred as a result of partial vesting of restricted stock granted on March 4, 2014."}],"balance_after":35602,"source":{"system":"sec-edgar","filing":"0001645282-17-000004","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/10456/000164528217000004/edgar.xml","form_type":"4"}},{"id":4399721,"issuer":{"id":1707,"kind":"organization","name":"BAXTER INTERNATIONAL INC","symbol":"BAX"},"owners":[{"id":42011,"kind":"person","name":"Schabacker Marcus","position":1,"cik":"0001645282","reported_name":"Schabacker Marcus","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP, Chief Scientific Officer"}}],"security":"Common Stock, $1 par value","published_at":"2017-03-07T21:13:55.000Z","date":"2017-03-03","kind":"tax_withholding","acquired":false,"shares":1454,"price":50.91,"value":74023.14,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares forfeited by the reporting person to cover the payment of taxes incurred as a result of partial vesting of restricted stock granted on March 3, 2015."}],"balance_after":35889,"source":{"system":"sec-edgar","filing":"0001645282-17-000003","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/10456/000164528217000003/edgar.xml","form_type":"4"}},{"id":4402276,"issuer":{"id":1707,"kind":"organization","name":"BAXTER INTERNATIONAL INC","symbol":"BAX"},"owners":[{"id":42011,"kind":"person","name":"Schabacker Marcus","position":1,"cik":"0001645282","reported_name":"Schabacker Marcus","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP, Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-03-06T21:35:19.000Z","date":"2017-03-02","kind":"grant","acquired":true,"shares":42781,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes exercisable in three equal annual installments beginning on the first anniversary of the date of the grant."}],"balance_after":42781,"derivative":{"exercise_price":50.77,"expiration_date":"2027-03-02","underlying":"Common Stock,$1 par value","underlying_shares":42781},"source":{"system":"sec-edgar","filing":"0001645282-17-000002","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/10456/000164528217000002/edgar.xml","form_type":"4"}},{"id":4430545,"issuer":{"id":1707,"kind":"organization","name":"BAXTER INTERNATIONAL INC","symbol":"BAX"},"owners":[{"id":42011,"kind":"person","name":"Schabacker Marcus","position":1,"cik":"0001645282","reported_name":"Schabacker Marcus","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP, Chief Scientific Officer"}}],"security":"Common Stock, $1 par value","published_at":"2017-02-23T21:44:45.000Z","date":"2017-02-21","kind":"grant","acquired":true,"shares":5281,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents shares earned from the performance share unit award granted on March 3, 2016 pursuant to the Equity Plan adopted by Baxter as of such date.  The award provides that fifty percent of the performance share units are earned based on the Baxter's Adjusted Operating Margin (OM) performance, as assessed annually over a three-year period. One-third of the OM performance share units are allocated to each one-year period.  The number of shares reported on this Form 4 represents the shares earned based on Baxter's OM, as assessed from January 1, 2016 to December 31, 2016.  These shares are scheduled to vest after the end of the relevant three-year performance period (which runs from January 1, 2016 through December 31, 2018)."}],"balance_after":37190,"source":{"system":"sec-edgar","filing":"0001645282-17-000001","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/10456/000164528217000001/edgar.xml","form_type":"4"}},{"id":4430544,"issuer":{"id":1707,"kind":"organization","name":"BAXTER INTERNATIONAL INC","symbol":"BAX"},"owners":[{"id":42011,"kind":"person","name":"Schabacker Marcus","position":1,"cik":"0001645282","reported_name":"Schabacker Marcus","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP, Chief Scientific Officer"}}],"security":"Common Stock, $1 par value","published_at":"2017-02-23T21:44:45.000Z","date":"2017-02-21","kind":"tax_withholding","acquired":false,"shares":1375,"price":49.96,"value":68695.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the vesting of shares earned in 2014, 2015 and 2016 as part of the 2014 PSUs."}],"balance_after":31909,"source":{"system":"sec-edgar","filing":"0001645282-17-000001","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/10456/000164528217000001/edgar.xml","form_type":"4"}},{"id":4430543,"issuer":{"id":1707,"kind":"organization","name":"BAXTER INTERNATIONAL INC","symbol":"BAX"},"owners":[{"id":42011,"kind":"person","name":"Schabacker Marcus","position":1,"cik":"0001645282","reported_name":"Schabacker Marcus","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP, Chief Scientific Officer"}}],"security":"Common Stock, $1 par value","published_at":"2017-02-23T21:44:45.000Z","date":"2017-02-21","kind":"grant","acquired":true,"shares":2092,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares awarded from the 2014 PSUs.  The award provides that fifty percent of the performance share units are earned based on Baxter's Growth in Shareholder Value (GSV) performance over the Three-Year Performance Period.  The number of shares reported on this Form 4 represents the shares awarded based on Baxter's GSV during the Three-Year Performance Period.  These shares have vested as the Three-Year Performance Period has ended."}],"balance_after":33284,"source":{"system":"sec-edgar","filing":"0001645282-17-000001","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/10456/000164528217000001/edgar.xml","form_type":"4"}},{"id":4430542,"issuer":{"id":1707,"kind":"organization","name":"BAXTER INTERNATIONAL INC","symbol":"BAX"},"owners":[{"id":42011,"kind":"person","name":"Schabacker Marcus","position":1,"cik":"0001645282","reported_name":"Schabacker Marcus","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP, Chief Scientific Officer"}}],"security":"Common Stock, $1 par value","published_at":"2017-02-23T21:44:45.000Z","date":"2017-02-21","kind":"grant","acquired":true,"shares":1081,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares awarded from the performance share unit award granted on March 4, 2014 pursuant to the Equity Plan adopted by Baxter International Inc. (Baxter) as of such date (the 2014 PSUs). The award provides that fifty percent of the performance share units are earned based on Baxter's Return on Invested Capital (ROIC) performance, as assessed annually over a three-year period. One-third of the ROIC performance share units are allocated to each one-year period. The number of shares reported on this Form 4 represents the shares awarded based on Baxter's ROIC during the January 1, 2016 to December 31, 2016 performance period.  These shares have vested as the relevant three-year performance period January 1, 2014 to December 31, 2016 (the Three-Year Performance Period) has ended."}],"balance_after":31192,"source":{"system":"sec-edgar","filing":"0001645282-17-000001","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/10456/000164528217000001/edgar.xml","form_type":"4"}}]}